AZTA Azenta, Inc.
USHealthcareAs of 2026-07-10 16:00
Why AZTA matters now
Azenta, Inc. (AZTA) is a US stock in Healthcare. The latest InvestLog snapshot shows $25.36 with -0.24% on the session and $1.17B in market capitalization; recent performance reads 1-month +32.07% and YTD -29.92%.
The latest financial table shown here is Q2 2026, with revenue of $144.8M, net income of $-160.8M, and EPS of $-3.49. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.7%.
The latest indexable market news headline is "Azenta Completes Sale of B Medical Systems" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $45.00; recent insider activity includes Cornog William L filing P-Purchase; recent congressional disclosure data includes Gilbert Cisneros Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.69
P/S
1.80
EV/EBITDA
-9.65
DCF Value
$12.41
FCF Yield
2.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.6%
Operating Margin
-2.6%
Net Margin
-29.9%
ROE
-10.7%
ROA
-9.4%
ROIC
-0.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $144.8M | $-160.8M | $-3.49 |
| Q1 2026 | $148.6M | $-15.4M | $-0.34 |
| Q4 2025 | $159.2M | $50.9M | $1.02 |
| FY 2025 | $593.8M | $-55.8M | $-1.22 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$45.00
Target (Median)
$45.00
Target Range
$45.00 - $45.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
1.40
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.